Treatment Intensification in HIV-1 Patients With Multi-Drug Resistant Virus

Trial Profile

Treatment Intensification in HIV-1 Patients With Multi-Drug Resistant Virus

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 10 Dec 2015

At a glance

  • Drugs Enfuvirtide (Primary) ; Antiretrovirals
  • Indications HIV-1 infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 16 Sep 2008 Planned end date changed from 1 Mar 2006 to 1 Mar 2009 as reported by ClinicalTrials.gov.
    • 24 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top